Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)
PHASE2
To establish optimal dosing of lyophilized Fecal microbiota transplantation...
Status
Terminated
Location
The University of Texas Health Science Center at Houston
Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis
PHASE2
The purpose of the study is to evaluate the efficacy and safety of lyophili...
Status
Recruiting
Location
The University of Texas Health Science Center at Houston
A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally in Subjects With Nonalcoholic Fatty Liver Disease
PHASE2
Potential subjects with non-alcoholic fatty liver disease (NAFLD) will be i...